Cyred Eq Kit
Product Images NDC 63629-5649

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cyred Eq (NDC 63629-5649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Deso Ethi Fig1)

Figure 1. Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (Deso Ethi Fig1)
A bar chart showing mortality rates (number of deaths per 100,000 woman-years) by age group for four categories: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers). The age groups are 15-24, 25-34, 35-44, and 45 and older. Mortality rates increase with age, especially among ever-users who are smokers.*
FDA Label Image

Figure 2: Risk Of Breast Cancer With Combined Oral Contraceptive Use (Deso Ethi Fig2)

Figure 2: Risk Of Breast Cancer With Combined Oral Contraceptive Use (Deso Ethi Fig2)
A forest plot chart showing effect estimates (Odds Ratios or Relative Risks) with confidence intervals for various women's contraceptive studies between 2002 and 2017, comparing ever use and current use groups. The horizontal axis ranges from -1.5 to 2, with a vertical reference line at 1. The studies listed include NICHD, French E3N cohort, Shangai Women's Health, Nurses' Health II, Oxford Family Planning Association, and Danish Sex Hormone Register studies.*
FDA Label Image

Figure 3 (Deso Ethi Fig3)

Figure 3 (Deso Ethi Fig3)
Illustration of a 28-day tablet calendar for Cyred EQ oral contraceptive kit showing four rows labeled Week 1 to Week 4. Each row contains seven circular tablet indicators corresponding to days Sunday through Saturday, connected by arrows indicating the daily sequence. Weeks 1 to 3 tablets are white to off-white, and Week 4 tablets are green, with inactive tablets noted in Week 4. The bottom row includes the Cyred EQ name and active ingredient strengths (Desogestrel 0.15 mg and Ethinyl Estradiol 0.03 mg). Arrows guide the user through the daily dosing order over the 28 days.*
FDA Label Image

Chemical Structure (Deso Ethi Str)

Chemical Structure (Deso Ethi Str)
Chemical structures of the active ingredients desogestrel and ethinyl estradiol. Each structure shows the molecular arrangement of atoms and bonds specific to desogestrel and ethinyl estradiol, labeled accordingly at the top of the image.*
FDA Label Image

Label (Lbl636295649)

Label (Lbl636295649)
Label for Cyred EQ 0.15 mg/0.03 mg kit containing 6 blister cards of 28 tablets each. It lists active ingredients desogestrel and ethinyl estradiol, includes storage instructions, and states the package is not child-resistant. The label shows NDC 63629-5649, repackaged by Bryant Ranch Prepack and manufactured by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.